Healthcare -
Biotechnology - NASDAQ - US
$ 41.0
1.84 %
$ 3.8 B
Market Cap
-11.08
P/E
CRNX - LONG-TERM INVESTMENTS
Long-term Investments CRNX - Crinetics Pharmaceuticals, Inc.
1.77 M
LAST VALUE
32.38%
2 YEAR CAGR
28.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR